Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
ESTROGENS CONJUGATED
B & S Healthcare
G03CA57
ESTROGENS CONJUGATED
0.625 Milligram
Tablet Prolonged Release
Product subject to prescription which may not be renewed (A)
Natural and semisynthetic estrogens, plain
Authorised
2009-07-24
PACKAGE LEAFLET: INFORMATION FOR THE USER PREMARIN ® 0.625MG PROLONGED-RELEASE TABLETS PREMARIN ® 1.25MG PROLONGED-RELEASE TABLETS (conjugated estrogens) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. The name of your medicine is Premarin 0.625mg Prolonged-release Tablets and Premarin 1.25mg Prolonged-release Tablets, but it will be referred to as Premarin throughout this leaflet. WHAT IS IN THIS LEAFLET: 1. WHAT PREMARIN IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE PREMARIN 3. HOW TO TAKE PREMARIN 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE PREMARIN 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT PREMARIN IS AND WHAT IT IS USED FOR Premarin is a Hormone Replacement Therapy (HRT). It contains the female hormone estrogen. Premarin is used to treat some of the symptoms and conditions associated with the menopause. Premarin is usually prescribed for women who have had their womb removed (hysterectomy). However women who have not had this operation can still take Premarin and their doctor may prescribe a second type of tablet containing another hormone called a progestogen to be taken 12-14 days per month as well as the Premarin tablets. Premarin is used for: RELIEF OF SYMPTOMS OCCURRING AFTER MENOPAUSE During the menopause, the amount of the estrogen produced by a woman’s body drops. T Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Premarin 0.625 mg Prolonged-release tablets. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 0.625mg conjugated estrogens. Excipients: Each prolonged-release tablet contains sucrose and lactose. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Prolonged-release tablet. _Product imported from the UK:_ Maroon, oval, biconvex, sugar-coated tablet marked with “0.625” in white ink. 4 CLINICAL PARTICULARS As per PA 0822/095/002. 5 PHARMACOLOGICAL PROPERTIES As per PA 0822/095/002. 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS lactose monohydrate microcrystalline cellulose magnesium stearate hypromellose sucrose hydroxypropyl cellulose macrogol carnauba wax edible ink and coating. The edible ink on maroon tablets contains hypromellose titanium dioxide (E171) propylene glycol (E1520). The coating on the maroon tablets contains hypromellose titanium dioxide (E171) red aluminium lake (E129) indigo carmine (E132) macrogol. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 18/11/2014_ _CRN 2120507_ _page number: 1_ 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf life expiry date of this product shall be the date shown on the container and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25°C. 6.5 NATURE AND CONTENTS OF CONTAINER Polyvinylchloride (PVC)/Aluminium foil blisters containing 28 tablets. One carton pack contains 3 blisters. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT No special requirements 7 PARALLEL PRODU Read the complete document